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Abstract

Background: The measurement of follicular output rate (FORT) has been proposed as a
good indicator for evaluating follicular response to the exogenous recombinant folliclestimulating hormone (rFSH). This places FORT as a promising qualitative marker for
ovarian function. The objective of the study was to determine FORT as a predictor of
oocyte competence, embryo quality and clinical pregnancy after intracytoplasmic sperm
injection (ICSI).
Materials and Methods: This prospective study was carried out on a group of infertile females (n=282) at Islamabad Clinic Serving Infertile Couples, Islamabad, Pakistan, from June 2010 till August 2013. Down- regulated females were stimulated in
injection gonadotropins and on ovulation induction day, pre-ovulatory follicle count
(PFC) was determined using transvaginal ultrasound scan (TVUS), and FORT was
determined as a ratio of PFC to antral follicle count (AFC)×100. Group I consisted of
females with a negative pregnancy test, while group II had a positive pregnancy test
that was confirmed with the appearance of fetal cardiac activity. Linear regression
analyses of categorical variables of clinical pregnancy along with other independent
variables, including FORT, were performed using SPSS version 15.0.
Results: Pregnancy occurred in 101/282 women who were tested, recording a clinical
pregnancy rate of about 35.8%. FORT values were higher in group II as compared to
group I females (P=0.0001). In multiple regression analysis, 97.7, 87.1, 78.2, and 83.4%
variations were explained based on the number of retrieved oocytes per patients, number
of metaphase II oocytes retrieved, number of fertilized oocytes, and number of cleaved
embryos, respectively, indicating FORT as an independent predictor.
Conclusion: FORT is a predictor of oocyte competence in terms of a number of retrieved,
mature and fertilized oocytes. It also gives information about the number of cleaved embryos and clinical pregnancy rate.
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Introduction
The prevalence of infertility in Pakistan is
21.9%, which accounts for approximately 3.5
to 3.9% cases of primary infertility and 18.0 to
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18.4% of secondary infertility (1). The assisted reproductive clinics offer scientific assistance to infertile couples for the commencement of pregnancy preparation. Assisted reproductive techniques
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include in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) for the treatment
of infertile couples (2, 3).
In ICSI, after the down-regulation of ovaries,
controlled ovarian hyperstimulation (COH) is followed by ovulation induction (OI) and oocyte pickup, after which a single sperm is introduced in the
ooplasm, placed under a microscope. The procedure
has shown a greater success rate as compared to IVF.
Ovarian stimulation is a key procedure necessary to
achieve success in assisted reproductive techniques.
Stimulation is achieved by the administration of exogenous gonadotropins in the form of recombinant
follicle stimulating hormone (rFSH) in order to increase the follicular recruitment and oocyte yield.
Confirmation of responsiveness of ovarian reservoir
to FSH in terms of the development of the antral
follicles is so far a challenge for reproductive endocrinologists at clinics (1, 4). The appropriate response of antral follicles to FSH and a high-quality
oocyte may result in a positive impact on outcomes
of IVF and ICSI. Poor response to COH results in
retrieval of few oocytes with reduced number of
embryos available for transfer, leading to a decrease
in pregnancy rates (2).
The endocrinologists, thus, devised various
methods to assess the ovarian reservoir and the
expected responsiveness. Antral follicle count
(AFC) is one of the non- invasive methods used
for the assessment of the sensitivity of antral follicles to FSH (5). AFC represents the number of
remaining primordial pool which corresponds to
the number of oocytes retrieved; however, it does
not influence the number of oocytes, embryo quality and the outcome of ICSI (6). The number of
pre-ovulatory follicle count (PFC) obtained at the
end of COH is estimated to be the best indicator of
the number of retrieved oocytes (2, 3, 7).
However, it also includes the number of small
antral follicles available before treatment (8, 9). It
means that follicular output rate (FORT) determines
follicular response to exogenous rFSH by the ratio
of pre-ovulatory follicles to the existing pool of
small antral follicles. The index has been investigated as an indicator of existing ovarian reservoir in
response to stimulation and oocyte competence by
a number of researchers (1, 4, 5). In addition to assessing ovarian function, we designed this study in
order to identify the value of FORT for the predic-
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tion of oocyte competence, embryo quality and the
likelihood of clinical pregnancy after ICSI.

Materials and Methods
This prospective study was carried out at Islamabad Clinic Serving Infertile Couples Islamabad, Pakistan, between June 2010 and August 2013 after
the ethical approval was obtained from the Ethical
Review Board of Islamabad Clinic Serving Infertile Couples, Islamabad, Pakistan. The study was
conducted in accordance with the principles of the
Declaration of Helsinki, and an informed written
consent was taken from all study participants. The
women (n=282) undergoing ICSI were included
in this study with the following criteria: infertility
duration of more than 2 years, age range of 21-40
years, regular menstrual cycle, normal morphological ovaries, body mass index (BMI) of 18-35 kg/
m2, and serum FSH levels lower than 8 IU/ml. The
exclusion criteria were as follows: polycystic ovary
syndrome (PCOS), uterine fibroids, down-regulation with short gonadotropin-releasing hormone
(GnRH)-agonist or -antagonist protocol, sperm retrieval by testicular biopsy, and use of IVF cycles.
Treatment protocol
The treatment protocol of females was carried
out as mentioned by Rehman et al. (3). Total number of AFC with a mean diameter of 3-8 mm was
determined using a transvaginal ultrasound scan
(TVUS) with a 7.5 MHz probe (Aloka Co., Japan).
COH was carried out using subcutaneous administration of 50 IU/day rFSH (Puregon, NV Organon,
The Netherlands). The initiation dose was calculated based on the of the age of the subject, basal
serum FSH concentrations, AFC and BMI (6). Dose
adjustment was done by follicular tracking with
TVUS, commenced from the fifth day of COH on
alternate days for assessment of follicular response
and measurement of endometrial thickness. During
the last days of COH, patients had to visit the assisted reproductive clinics daily for the appropriate
time of OI using human chorionic gonadotropin
(hCG) injection (1). On OI day, PFC was calculated as the total number of follicles with a mean
diameter of 16-22 mm in both ovaries using TVUS.
The FORT was calculated as the ratio of PFC on
OI day ×100/AFC (10). Approximately 37 hours
after hCG injection, oocyte pick-up was performed
under general anesthesia using a vaginal ultrasound
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probe, after which luteal support was provided with
the progesterone vaginal pessaries (Cyclogest 400
mg, Actavis Co., UK) twice a day. Transfer of blastocysts was performed seven days after hCG injection using Edwards-Wallace embryo replacement
catheter (SIMS Portex Ltd., UK) under ultrasound
guidance. Two blood samples were taken on days of
hCG injection and blastocyst transfer for estimation
of peak and mid-luteal levels of estradiol (E2) and
progesterone using enzyme linked immuno sorbent
assay (ELISA). Serum E2 and progesterone as well
as ELISA kits were provided by MP Biomedicals,
USA and BioSource, Belgium, respectively.
Outcome parameters
The marker for detection of pregnancy outcome was beta-hCG (β-hCG) levels that were
measured 14 days after egg collection. Clinical
pregnancy was identified by the appearance of a
gestational sac with cardiac activity using TVUS.
Therefore, the participants were divided into the
following groups: group I (n=181) including
non-pregnant women with β-hCG<25 mIU/ml,
and group II (n=101) including pregnant women
with β-hCG>25 mIU/ml and the presence of cardiac activity confirmed by TVUS. Pregnancy rate
was calculated by the presence of an intrauterine
gestational sac observed by TVUS per number of
patients in the cycle (5, 7).
Statistical analysis
Data was analyzed by Statistical Package for
Social Science software (SPSS, SPSS Inc., USA)
version 15.0. The stepwise backward method
was used to estimate the best model using FORT
as a predictor that was adjusted with other clinical risk factors affecting clinical pregnancy outcome, including female age, BMI, FSH, duration
of infertility, the length of stimulation, AFC, and
PFC. A variable is entered into the model if the
significance level of its F value is less than 0.05
and removed if the significance level is greater
than 0.10. Four different models were developed
showing that FORT gave significant effect on the
number of oocytes/patient, the number of metaphase II oocytes retrieved, the number of cleaved
embryos and number of fertilized oocytes. In regression analysis, R-squared (R2, coefficient of
determination) described variation in dependent
variable with respect to independent variable(s),

while Spearman’s Rank Correlation was used to
investigate the correlation of clinical pregnancy
with different parameters. A P value less than 0.05
was considered to be statistically significant.

Results
Baseline characteristics of study participants are
given in Table 1. Pregnancy occurred in 101/282
women who were tested, recording a clinical
pregnancy rate of about 35.8%. Table 2 explains
the significant difference regarding FORT values
in group I (49.31 ± 12.83) and II (64.17 ± 8.96).
Table 1: Baseline characteristics of the infertile subjects

Parameters

Mean

Female age (Y)

32.18

SD
4.72

Duration of infertility (Y)

7.46

4.01

Length of stimulation (days)

14.16

0.96

AFC

13.07

2.56

PFC

8.31

1.71

FORT

64.09

8.97

No. of oocytes/patient

8.21

1.53

No. of metaphase II oocytes
retrieved

8.03

1.45

No. of fertilized oocytes

6.65

1.07

No. of cleaved embryos

6.56

1.04

Peak progesterone (ng/ml)

0.85

0.45

Mid-luteal progesterone (ng/ml)

89.17

32.84

Peak E2 (pg/ml)

2529.06

193.99

Mid-luteal E2 (pg/ml)

1109.46

136.29

Endometrial thicknessa (mm)

1.74

0.44

Values are presented as mean ± SD. AFC; Antral follicle count, PFC; Preovulatory follicle count, FORT; Follicular output rate, and E2; Estradiol.
Table 2: Comparison of the parameters between group I
(non-pregnant participants) and group II (pregnant participants)

Parameters

Nonpregnant
participants
n=181

Pregnant
participants
n=101

P value

Female age (Y) 32.11 ± 4.61

32.107 ± 4.74

0.952

Duration of
infertility (Y)

6.94 ± 3.78

7.40 ± 4.02

0.409

Length of
stimulation
(days)

14.43 ± 0.96

14.15 ± 0.95

- 0.454

Dose of
rFSH/day

3.89 ± 1.43

4.29 ± 2.96

<0.001
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Table 2: Continued

Parameters

Nonpregnant
participants
n=181

Pregnant
participants
n=101

P value

AFC

15.57 ± 2.51

13.04 ± 2.55

0.559

PFC

7.52 ± 1.90

8.30 ± 1.69

0.364

FORT

49.31 ± 12.83

64.17 ± 8.96

<0.001

No. of
cleaved embryos

5.45 ± 1.53

6.56 ± 1.03

<0.001

Endometrial
thickness (mm)

1.26 ± 0.44

1.74 ± 0.43

0.819

No. of oocytes/
patient

7.40 ± 1.68

8.20 ± 1.51

0.296

No. of mature
oocytes/patient

6.61 ± 2.03

8.02 ± 1.43

0.004

No. of fertilized
oocytes

5.54 ± 1.64

6.65 ± 1.06

<0.001

Peak E2 (pg/ml)

2207.97 ± 283.73

2529.06 ± 193.35

<0.01

Mid-luteal E2
(pg/ml)

899.49 ± 122.05

1109.46 ± 135.83

<0.01

Peak progesterone (ng/ml)

1.96 ± 0.67

1.12 ± 0.59

<0.01

Mid-luteal
progesterone
ng/ml

192.44 ± 20.34

116.51 ± 48.60

<0.01

Values are presented as mean ± SD. rFSH; Recombinant folicle
stimulating hormone, AFC; Antral follicle count, PFC; Pre ovulatory follicle count, FORT; Follicular output rate, and E2; Estradiol.

It indicates that the length of stimulation, AFC (r=0.412, P<0.01), as well as peak (r=-0.640, P<0.01)
and mid-luteal progesterone levels (r=-0.802, P<0.01)

showed a significant negative association with clinical pregnancy outcome. However, FORT (r=0.532,
P<0.001), PFC (r=0.265, P<0.01), number of cleaved
embryos (r=0.365, P<0.01), peak (r=0.640, P<0.01)
and mid-luteal (r=0.679, P<0.01), E2 (r=0.640,
P<0.01) levels, as well as endometrial thickness
(r=670, P<0.01) showed a significant positive correlation with clinical pregnancy outcome (Table 3). Linear
regression analysis of FORT as an independent predictor described variations of 97.7, 87.1, 78.2 and 83.4%
for the number of retrieved oocytes per patients, number of metaphase II oocytes retrieved, the number of
fertilized oocytes, and the number of cleaved embryos,
respectively (Table 4). Furthermore, table 4 shows an
increase in FORT value by one unit increased the mean
number of oocytes/patients (β coefficient: 0.135),
while the model was adjusted for length of stimulation and AFC with an adjusted R2 value of 97.7%. The
model describes that an increase in FORT value by one
unit increased the mean number of metaphase II oocytes retrieved (β coefficient: 0.128), while the model
was adjusted for FSH and AFC with an adjusted R2
value of 87.1%. The model also describes that an increase in FORT value by one unit will give a positive
impact on the mean number of oocytes fertilized (β
coefficient: 0.089), while the model was adjusted for
FSH and AFC with an adjusted R2 value of 78.2 %.
However, the model suggested that one unit increase
in FORT value decreased the mean number of cleaved
embryos (β coefficient: -0.025), while it was adjusted
for AFC and number of metaphase II oocytes retrieved
(Table 4).

Table 3: Comparison of the parameters for clinical pregnancy outcome using Spearman rank correlation

Predictors

Clinical pregnancy r(P value)

Female age (Y)

0.001(0.981)

Duration of infertility (Y)

0.052(0.380)

Length of stimulation (days)

-0.140*(0.018)

AFC

-0.412*(<0.01)

PFC

0.265*(<0.01)

FORT

0.532*(<0.01)

No. of cleaved embryos

0.365*(<0.01)

Peak progesterone (ng/ml)

-0.652*(<0.01)

Mid luteal progesterone (ng/ml)

-0.802*(<0.01)

Peak E2 (pg/ml)

0.640*(<0.01)

Mid luteal E2 (pg/ml)

0.679*(<0.01)

Endometrial thickness

0.628*(<0.01)

AFC; Antral follicle count, PFC; Pre-ovulatory follicle count, FORT; Follicular output rate, E2; Estradiol, *; Correlation with P<0.05 considered as significant, and
r; Spearman rank correlation.
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Table 4: Regression models with FORT as an independent predictor

Regression models

Independent predictor

Beta coefficient

SE

Adjusted R2

P value

FORT

0.135

± 0.003

97.7%

<0.01*

No. of metaphase II oocytes retrievedb

FORT

0.128

± 0.006

87.1%

<0.01*

No. of fertilized oocytes

FORT

0.089

± 0.006

78.2%

<0.01*

No. of cleaved embryosd

FORT

-0.025

± 0.01

83.4%

0.019*

No. of oocytes/patients

a

c

FORT; Follicular output rate, R2; Coefficient of determination, AFC; Antral follicle count, FSH; Follicle stimulating hormone, a; Adjusted
with length of stimulation and AFC, b, c; Adjusted with FSH and AFC, d; Adjusted with AFC and number of metaphase II oocytes retrieved
and *; P<0.05 was considered as significant.

Discussion
The successful outcome in assisted reproductive
clinics depends on embryos and endometrial qualities. The quality of embryos depends on number
and quality of oocytes, which in turn is considered
as a measure of antral follicles responsiveness to
FSH; however, no pointer can predict both ovarian
response and oocyte competence. FORT, in this regard, can be used as an innovative marker to predict
ovarian response and oocyte competence, leading to
increase the chances of clinical pregnancy (8).
AFC as a non-invasive method of assessment
plays a key role in the prediction of ovarian response and provides a valuable insight into the
sensitivity of antral follicles to FSH (5). In this
study, AFC showed significant negative association with the pregnancy outcome. Similar to our
findings, a study reported that AFC represented
the actual ovarian reserve and were highly correlated with the number of oocytes retrieved (6).
Furthermore, other studies concluded that AFC
cannot predict the oocyte/embryo quality or IVF/
ICSI outcome and showed better FORT results in
subjects with decreased AFC (4, 11). A study declared that AFC obtained at the end of stimulation
is the best indicator of the number of retrieved
oocytes and good clinical outcome (7). However,
a contrasting observation was noted in another
study where pre-ovulatory follicles were not observed as an appropriate reflector of antral follicle sensitivity to FSH (12). The conflict can thus
be resolved by the use of FORT index, which can
reflect ovarian follicular competence in response
to stimulation (4, 5).
High FORT showed a higher rate of clinical
pregnancies that can be explained on the basis of
its association with basal, peak and mid-luteal E2
concentrations (8). The role of high FORT in in-

creasing peak E2 concentrations can be explained
by increased retrieval, maturity and fertilization of
oocytes, which potentially lead to an increase in
clinical pregnancy rate (10, 13, 14). Enhanced midluteal E2 concentration in females with high FORT
increases the chance of pregnancy, which is also
supported by other studies (3-8, 15).
The exact role of progesterone in determining the
success of IVF/ ICSI is a subject of debate. Our results showed that females with high FORT had low
peak progesterone levels, which is similar to another
study in which pregnancy rate was inversely related
to serum progesterone levels (16). However, in contrast to these results, a study proved that progesterone enhances uterine receptivity by the maturation
of mast cells that produce cytokines and growth
factors (17, 18). Hofmann et al. (19) observed no
significant difference in pregnancy rate in patients
undergoing IVF/embryo transfer with high or low
progesterone concentrations on the day of hCG administration and in patients receiving oocytes donated from women with high or low progesterone
concentrations. The role of FORT in the prediction
of clinical pregnancy can thus be emphasized on the
basis of its effect on hormones of implantation.
It seems that FORT is a qualitative indicator of
ovarian follicles competence and has a significant
correlation with the clinical pregnancy outcome.
Our results showed that it has positive effects on
a number of oocytes/patient, the number of metaphase II oocytes retrieved, the number of cleaved
embryos and number of fertilized oocytes. Similar
to other two studies that reflected the rates of good
quality embryos and embryo implantations, clinical
pregnancies increased dramatically in accordance
with FORT values (4, 20). Besides the importance
of the impact of FORT on clinical pregnancy, it was
a unicentric study in which different sonologists
determined AFC and PFC which must be standardInt J Fertil Steril, Vol 10, No 2, Jul-Sep 2016
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ized for uniformity . The variation in marking AFC
and PFC by different sonographers is unlikely to be
ruled out.

Conclusion

9.

10.

FORT is a predictor of oocyte competence in terms
of a number of retrieved, mature and fertilized oocytes.
The indicator can be used for prediction of clinical
pregnancy rate after ICSI. It also gives information
about the number of cleaved embryos and clinical
pregnancy rate which needs to be further explored.

11.

12.
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